Anti-Human C16orf54 Therapeutic Antibody scFv Fragment (R29-67-1 B)

This antibody can specifically bind to C16orf54, which can be used in the treatment of CLL and other hematologic cancers, including acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), lymphoma, including Hodgkin and non-Hodgkin lymphoma, multiple myeloma, as well as solid tumors such as breast cancer and pancreatic cancer, and metastases of any of these cancers.
Supplier Creative Biolabs
Product # TAB-1325CL-S(P)
Pricing Inquiry
Host Mouse
Target C16orf54
Feedback